Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer
Clinical trial NCT03497702 · UNKNOWN
Trial details
- NCT number
- NCT03497702
- Sponsor
- National Cancer Center, Korea
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-08
- Primary completion
- 2023-11-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.